FDA Drug recall D-1191-2018
Tizanidine HCl Tablets, USP 2mg, 150-count bottles, Rx Only, Mfd
- FDA Drug
- Class II
- terminated
- Published 2018-09-26
On 2018-09-26 the FDA classified a Class II recall of Tizanidine HCl Tablets, USP 2mg, 150-count bottles, Rx Only, Mfd by Dr Reddy S Laboratories, citing presence of Foreign Tablets/Capsules: Glimepiride tablet was found in a bottle of Tinzadine Hcl Tablets .
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1191-2018 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2018-09-04 |
| Published | 2018-09-26 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Dr Reddy S Laboratories |
| Distribution | US |
Product
Tizanidine HCl Tablets, USP 2mg, 150-count bottles, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited Srilakulam - 532 409 INDIA, NDC 55111-179-15, UPC 35511179153
Reason
Presence of Foreign Tablets/Capsules: Glimepiride tablet was found in a bottle of Tinzadine Hcl Tablets .
Identifiers
| ndc | 55111-179-30 |
|---|---|
| ndc | 55111-179-15 |
| ndc | 55111-179-03 |
| ndc | 55111-179-10 |
| ndc | 55111-180-30 |
| ndc | 55111-180-15 |
| ndc | 55111-180-03 |
| ndc | 55111-180-10 |
| ndc | 3551117915 |
| code_info | Lot #: T800304, Exp. 03/2021 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1191-2018%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.